Back to top

View the PFP Archive

ZACKS
Not Again!

Yesterday I likened this current market to the mythological Greek character, Sisyphus. That being how each day we roll stocks up a hill to new heights only to have it slide back down again.

Wednesday served up more of the same as shares broke above 1850 yet again in the morning. Then by the close it was right back down again.

This cycle will break soon. Odds point to that being to the upside with 1900 a logical next target. However, if there is a fresh round of bad economic news on the way, or a new international "Risk Off" scare, then 1800 is our next destination.

My money continues to ride on 1900 coming first.

Now let me you turn your attention to a chronic problem for most investors. And gladly Kevin Matras has the cure in his latest strategy article:

Your Biggest Obstacle to Trading Success?

Plus Other Featured Commentaries:

•  Roundtable Top Picks for the Week

•  Biotech Stock Review

Best,

Steve Reitmeister (aka Reity...pronounced "Righty")

Executive Vice President

Zacks Investment Research

Follow Us:  

Sponsor

R.I.P. Internet -- 1969-2014
At only 45 years old... the Internet will be laid to rest in 2014. And Silicon Valley is thrilled. In fact, the CEO of Cisco Systems -- one of the largest tech companies on the planet -- says somebody's going to bank "14.4 trillion in profit from one concept alone." Click here for a FREE video that gives you what you need to capitalize on the little-known company behind this concept.

Bull & Bear of the Day

Zacks Rank #1

Acuity Brands (AYI)

This lighting fixture manufacturer has a bright earnings outlook and a stock price that is thundering through resistance.

 

Zacks Rank #5

Wellcare Heath (WCG)

Analysts gave this insurance provider a check up recently and revised earnings estimates to the downside.


Stock Picking Strategies

States with Higher Minimum Wage Have Higher Unemployment, Prices  ››

Missed the Rally? Grab 3 Off-the-Radar Stocks  ››

Enter Biosimilars: 3 Stock Picks  ››


Funds Commentary

Zacks #1 Ranked Growth Mutual Funds  ››

Are Housing ETFs in Trouble?  ››

Japan ETFs in Focus as BOJ Boosts Loan Programs  ››


Options Strategies

How To Determine the Correct Position Size  ››


Video Reports

Muted Market Reaction to Recent Economic News

Zacks experts weigh in on the stock market's seesaw action amid mixed US economic data.

Three Global Tech Firms to Invest In

Info Tech Advancement Is Tying the World Together.

Roundtable Top Picks for the Week of Feb. 24th

Ideas for ETFs, Pharmaceuticals and REITS. Opportunities covered include Market Vectors Wide Moat ETF (MOAT), Ariad Pharmaceuticals (ARIA) and Excel Trust (EXL).

Earnings HQ

Today's Noteworthy Earnings Before the Bell:   ››  TDTEFVRXCMFMX

Today's Noteworthy Earnings After the Bell:   ››  CRMGPSROSTBRFSMNST

Get the First Calendar Made for Traders.

Visit the Zacks Earnings Calendar

Recent Earnings Winners

Company Symbol Reported Surprise %Price Chg
ANIKA THERAPEUTICS INC ANIK Feb 26 +0.44% +33.16%
EDGEWATER TECHNOLOGY INC EDGW Feb 26 +0.16% +20.30%
5N PLUS INC FPLSF Feb 26 +0.03% +17.23%
MIDDLEBY CP MIDD Feb 26 +2.62% +13.56%
ABERCROMBIE & FITCH CO ANF Feb 26 +1.34% +11.25%

See All »

Best Earnings ESP Stocks  

Company Symbol Consensus
Est.
Most
Accurate Est.
Reports Zacks Rank ESP
SHIP FIN INTL SFL 0.19 0.29 Feb 27 1 +52.63
ALACER GOLD CP T.ASR 0.05 0.07 Mar 12 1 +40.00
CONSTELLATN-TS T.CSU 2.66 2.79 Mar 5 1 +4.89
MAGNA INTL A-TS T.MG 1.57 1.68 Mar 7 1 +7.01
MAGNA INTL CL A MGA 1.52 1.53 Mar 3 2 +0.66
Don't trade these stocks until you have read the Zacks ESP Guide

Sponsor

Write down this important date: July 1st, 2014

On Tuesday July 1st, 2014, an important provision of a new law, House of Representatives Bill #2847, goes into effect.

So far, this story is being totally ignored by the mainstream press.

But this is one of the most important and dangerous pieces of legislation in modern U.S. history. It's going to cause major, major problems for every American and anyone around the globe holding U.S. dollars.

You have less than 5 months to prepare. Get the critical facts for yourself here.




Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe All         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
111 N. Canal St., Suite 1101
Chicago, Illinois 60606

Please login to Zacks.com or register to post a comment.